The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
AbbVie (stock symbol: ABBV) dividend yield (TTM) as of November 21, 2024 : 3.70%Average dividend yield, last 5 years: 4.16%